Envelope icon

Subscribe to our newsletter

Get regular updates to your inbox.

MN-166 (Ibudilast)

MN-166 (ibudilast) is being developed by MediciNova to treat amyotrophic lateral sclerosis (ALS) and works by suppressing pro-inflammatory cytokines.